Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Income	-76.7	-205.19	-142.31	-80.03	-125.71	-9.99	-13.02	-43.16	-10.82	-15.02	Upgrade
Depreciation & Amortization	1.02	1.02	0.3	0.26	0.26	0.05	0.07	0.06	0.02	0.07	Upgrade
Share-Based Compensation	3.31	8.9	12.7	8.58	17.84	0.76	1.08	1.58	0.61	0.08	Upgrade
Other Operating Activities	1.96	48.6	24.48	16.09	51.11	0.99	-4.39	3.61	0.62	1.96	Upgrade
Operating Cash Flow	-70.41	-146.67	-104.83	-55.1	-56.5	-8.2	-16.25	-37.91	-9.57	-12.9	Upgrade
Capital Expenditures	-0.34	-2.94	-2.25	-0.16	-0.01	0	0	-0.23	-0.02	-0.02	Upgrade
Acquisitions	0	0.25	0.25	0.25	2.15	0	0	0	0	0	Upgrade
Change in Investments	-	-	-8.48	-8.23	-	-	-	-	-	-	Upgrade
Other Investing Activities	-	-	16.72	0.03	-	0.01	0	-0.2	-	0.1	Upgrade
Investing Cash Flow	-0.34	-2.69	6.23	-8.12	2.14	0.01	0	-0.43	-0.02	0.08	Upgrade
Dividends Paid	0	0	-47.13	-75.4	-0.16	0	0	0	0	0	Upgrade
Common Stock Issued	32.32	81.53	107.52	78.36	57.54	0	0	0	57.82	0	Upgrade
Share Repurchases	-0.02	-0.33	-2.87	75.4	0	0	0	42.13	0	0	Upgrade
Other Financing Activities	29.6	8.83	90.97	150.52	-2.97	0.03	-10.02	42.26	23.36	6.09	Upgrade
Financing Cash Flow	61.94	90.69	154.23	78.08	54.42	0.03	-10.02	0.14	81.17	6.09	Upgrade
Net Cash Flow	-8.81	-58.66	55.63	14.86	0.06	-8.17	-26.27	-38.2	71.58	-6.74	Upgrade
Free Cash Flow	-70.75	-149.61	-107.08	-55.26	-56.51	-8.2	-16.25	-38.14	-9.59	-12.93	Upgrade
Free Cash Flow Margin	-420.21%	-1814.73%	-24009.64%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-151.83	-2142.80	-2989.73	-2575.67	-4837.93	-7847.81	-13258.56	-31337.34	-7893.17	-10962.91	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.